The U.S. Securities and Exchange Commission is investigating Illumina over its controversial $7.1 billion acquisition of cancer test developer Grail, …
Experts cite stocks to buy after Fed rate cut
From March 2022 through July 2023, the Federal Reserve raised interest rates 11 times. Rate increases often hurt the economy by making borrowing more … Read More